170 related articles for article (PubMed ID: 15378807)
1. Staying ahead of the fourth horseman.
Rex JH
Nat Rev Microbiol; 2004 Sep; 2(9):684. PubMed ID: 15378807
[No Abstract] [Full Text] [Related]
2. Drug discovery.
Kennedy D
Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461
[No Abstract] [Full Text] [Related]
3. Surviving the blockbuster syndrome.
Service RF
Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
[No Abstract] [Full Text] [Related]
4. The brains behind blockbusters.
Couzin J
Science; 2005 Jul; 309(5735):728. PubMed ID: 16051786
[No Abstract] [Full Text] [Related]
5. Acquisitions not a cure for anti-infectives.
Bradley D
Nat Rev Drug Discov; 2005 Sep; 4(9):704-5. PubMed ID: 16178116
[No Abstract] [Full Text] [Related]
6. The great medicines scandal.
Richards T
BMJ; 2006 Jun; 332(7554):1345-6. PubMed ID: 16740527
[No Abstract] [Full Text] [Related]
7. Cutting the cost of drug development?
Rawlins MD
Nat Rev Drug Discov; 2004 Apr; 3(4):360-4. PubMed ID: 15060531
[No Abstract] [Full Text] [Related]
8. Creating effective medicinal chemistry collaborations in drug discovery.
Giardina GA; Raveglia LF
Future Med Chem; 2009 Apr; 1(1):3-6. PubMed ID: 21426065
[No Abstract] [Full Text] [Related]
9. Orphan drugs of the future?
Service RF
Science; 2004 Mar; 303(5665):1798. PubMed ID: 15031491
[No Abstract] [Full Text] [Related]
10. China's unique position in discovery and preclinical research.
Boutellier R; Ullman F
Drug Discov Today; 2007 Jan; 12(1-2):4-7. PubMed ID: 17198968
[No Abstract] [Full Text] [Related]
11. Concerns raised over declining antiinfectives R&D.
Fox JL
Nat Biotechnol; 2003 Nov; 21(11):1255-6. PubMed ID: 14595340
[No Abstract] [Full Text] [Related]
12. Productivity counts--but the definition is key.
Mervis J
Science; 2005 Jul; 309(5735):726. PubMed ID: 16051784
[No Abstract] [Full Text] [Related]
13. Break with tradition.
Jayaraman KS
Nature; 2006 Jul; 442(7101):342-3. PubMed ID: 16871181
[No Abstract] [Full Text] [Related]
14. An uncertain call to arms.
Fraser CM
Science; 2004 Apr; 304(5669):359. PubMed ID: 15087509
[No Abstract] [Full Text] [Related]
15. [The economics of therapeutic investigations (author's transl)].
Poisvert M
Anesth Analg (Paris); 1980; 37(9-10):619-20, 623-6. PubMed ID: 7469079
[No Abstract] [Full Text] [Related]
16. Drug target validation: Hitting the target.
Smith C
Nature; 2003 Mar; 422(6929):341, 343, 345 passim. PubMed ID: 12646927
[No Abstract] [Full Text] [Related]
17. Wherefore art thou Romeo?
Cooper RD
Curr Opin Investig Drugs; 2004 Aug; 5(8):797-8. PubMed ID: 15602802
[No Abstract] [Full Text] [Related]
18. Pharma moves ahead cautiously in China.
Yidong G
Science; 2005 Jul; 309(5735):735. PubMed ID: 16051788
[No Abstract] [Full Text] [Related]
19. [Discount for only one drug of the same group leads to impaired health care quality].
Bergström R
Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044
[No Abstract] [Full Text] [Related]
20. Financial interests constrain drug development.
Garattini S
Science; 1997 Jan; 275(5298):287. PubMed ID: 9005546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
